BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3768011)

  • 1. Partial purification and characterization of a neutral insulin-like growth factor. Biochemical and biological properties.
    Minuto F; Barreca A; Del Monte P; Giordano G
    Biochem Int; 1986 Aug; 13(2):253-61. PubMed ID: 3768011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of human basic-somatomedin: comparison with insulin-like growth factors I and II.
    Bhaumick B; Goren HJ; Bala RM
    Horm Metab Res; 1981 Sep; 13(9):515-8. PubMed ID: 6271660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The somatomedin group of peptide growth factors.
    Van Wyk JJ; Furlanetto RW; Plet AS; D'Ercole AJ; Underwood LE
    Natl Cancer Inst Monogr; 1978 May; (48):141-7. PubMed ID: 748748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial purification, characterization, and assay of a slightly acidic insulin-like peptide (ILAs) from human plasma.
    Posner BI; Guyda HJ; Corvol MT; Rappaport R; Harley C; Goldstein S
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1240-50. PubMed ID: 400741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a low-molecular-weight plasma peptide which stimulates chick chondrocyte metabolism.
    Pickart L
    J Supramol Struct; 1980; 13(3):385-94. PubMed ID: 7009990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplication stimulating activity (MSA) from the BRL 3A rat liver cell line: relation to human somatomedins and insulin.
    Rechler MM; Nissley SP; King GL; Moses AC; Van Obberghen-Schilling EE; Romanus JA; Knight AB; Short PA; White RM
    J Supramol Struct Cell Biochem; 1981; 15(3):253-86. PubMed ID: 6267316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The somatomedins: a family of insulinlike hormones under growth hormone control.
    Van Wyk JJ; Underwood LE; Hintz RL; Clemmons DR; Voina SJ; Weaver RP
    Recent Prog Horm Res; 1974; 30(0):259-318. PubMed ID: 4366786
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin-like growth factor characteristics of an acidic non-suppressible insulin-like activity.
    Herington AC; Kuffer AD
    Biochem J; 1984 Oct; 223(1):89-96. PubMed ID: 6388566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The purification and partial characterization of human somatomedin C.
    Liberti JP; Miller MS
    J Biol Chem; 1980 Feb; 255(3):1023-9. PubMed ID: 7356647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and partial characterization of six somatomedin-like peptides from human plasma Cohn fraction IV.
    Blum WF; Ranke MB; Bierich JR
    Acta Endocrinol (Copenh); 1986 Feb; 111(2):271-84. PubMed ID: 3953237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of a somatomedin from plasma of rats bearing growth hormone secreting tumors.
    Chochinov RH; Mariz IK; Daughaday WH
    Endocrinology; 1977 Feb; 100(2):549-56. PubMed ID: 188631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelationships among receptor structures for insulin and peptide growth factors.
    Czech MP; Oppenheimer CL; Massagué J
    Fed Proc; 1983 Jun; 42(9):2598-601. PubMed ID: 6303863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The purification and partial characterization of an insulin-like protein from human serum.
    Poffenbarger PL
    J Clin Invest; 1975 Dec; 56(6):1455-63. PubMed ID: 1202080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of rat insulin-like growth factor II.
    Greenstein LA; Gaynes LA; Romanus JA; Lee L; Rechler MM; Nissley SP
    Methods Enzymol; 1987; 146():259-69. PubMed ID: 2960870
    [No Abstract]   [Full Text] [Related]  

  • 15. Integral membrane protein translocations in the mechanism of insulin action.
    Cushman SW; Simpson IA
    Biochem Soc Symp; 1985; 50():127-49. PubMed ID: 3915867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in serum receptor-reactive somatomedin in diabetes.
    Baxter RC; Brown AS; Turtle JR
    Horm Metab Res; 1979 Mar; 11(3):216-20. PubMed ID: 221310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common mechanism of action of somatomedin and insulin on fat cells. Further evidence.
    Clemmons DR; Hintz RL; Underwood LE; Van Wyk JJ
    Isr J Med Sci; 1974 Oct; 10(10):1254-62. PubMed ID: 4373414
    [No Abstract]   [Full Text] [Related]  

  • 18. Explorations of the insulinlike and growth-promoting properties of somatomedin by membrane receptor assays.
    van Wyk JJ; Underwood LE; Baseman JB; Hintz RL; Clemmons DR; Marshall RN
    Adv Metab Disord; 1975; 8():127-50. PubMed ID: 173158
    [No Abstract]   [Full Text] [Related]  

  • 19. A method for the purification of bovine somatomedin C.
    Glick BR; Michalak M
    Prep Biochem; 1987; 17(1):9-24. PubMed ID: 3588554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity modulation of human placental insulin and insulin-like growth factor receptors by lectins.
    Masnikosa R; Nikolić A; Nedić O
    J Biochem; 2008 Jun; 143(6):813-20. PubMed ID: 18316333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.